by Jordana Choucair | Oct 21, 2021 | Life Sciences
The FDA authorized recipients of Moderna’s two-dose COVID-19 vaccine and Johnson & Johnson’s single-dose shot to receive a booster shot. The agency also authorized a “mix and match” strategy, allowing medical providers to give people a booster shot of a different...
by Jordana Choucair | Oct 19, 2021 | Life Sciences
The FDA is moving toward a policy that would permit U.S. adults to receive a COVID-19 booster shot different from what they initially were administered. According to people familiar with the planning, the agency could recommend keeping brand consistency for a booster...
by Jordana Choucair | Oct 18, 2021 | Life Sciences
The FDA’s vaccine expert panel on Friday unanimously endorsed a booster shot for adult recipients of Johnson & Johnson’s COVID-19 vaccine at least two months after the initial dose. According to J&J, the second dose of its vaccine given 56 days...
by Jordana Choucair | Oct 15, 2021 | Life Sciences
A panel of outside advisers to the FDA voted unanimously to recommend a half-dose booster shot for some Americans who received Moderna’s COVID-19 vaccine at least six months ago. The advisers recommended that seniors, as well as younger adults with other health...
by Jordana Choucair | Oct 14, 2021 | Life Sciences
New documents released by the FDA indicate that mixing and matching the COVID-19 vaccines could be done safely. According to the documents, recipients of Johnson & Johnson’s COVID-19 vaccine may benefit from a second shot. However, separate data collected by...
by Jordana Choucair | Oct 13, 2021 | Life Sciences
Moderna is pressing the FDA to authorize a half-size booster of its COVID-19 vaccine, but agency scientists say the company has not met all the requirements to support boosters. In a briefing document, posted ahead of the agency’s meeting to discuss third doses of...
Recent Comments